FDA warns of risks with Trump-promoted malaria drug
|
April 24, 2020 9:03 AM
WASHINGTON (AP) — The U.S. Food and Drug Administration is warning doctors against prescribing a malaria drug widely touted by President Donald Trump for treating the new coronavirus outside of hospitals or research settings.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
